Here, we report that genome editing by CRISPR–Cas9 induces a p53-mediated DNA damage response and cell cycle arrest in immortalized human retinal pigment epithelial cells, leading to a selection against cells with a functional p53 pathway. Inhibition of p53 prevents the damage response and increases the rate of homologous recombination from a donor template. These results suggest that p53 inhibition may improve the efficiency of genome editing of untransformed cells and that p53 function should be monitored when developing cell-based therapies utilizing CRISPR–Cas9.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Hustedt, N. & Durocher, D. Nat. Cell Biol. 19, 1–9 (2016).
Hohmann, S. & Gozalbo, D. Mol. Gen. Genet. 211, 446–454 (1988).
Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L. & Corn, J. E. Nat. Biotechnol. 34, 339–344 (2016).
DeWitt, M. A. et al. Sci. Transl. Med. 8, 360ra134 (2016).
Yin, H. et al. Nat. Biotechnol. 32, 551–553 (2014).
Dever, D. P. et al. Nature 539, 384–389 (2016).
Lee, K. et al. eLife 6, e25312 (2017).
Maruyama, T. et al. Nat. Biotechnol. 33, 538–542 (2015).
Schmierer, B. et al. Mol. Syst. Biol. 13, 945 (2017).
Luo, M. & Chen, Y. Int. J. Ophthalmol. 11, 150–159 (2018).
Otto, T. & Sicinski, P. Nat. Rev. Cancer 17, 93–115 (2017).
Sokolova, M. et al. Cell Cycle 16, 189–199 (2017).
Doench, J. G. et al. Nat. Biotechnol. 34, 184–191 (2016).
Wang, J., Vasaikar, S., Shi, Z., Greer, M. & Zhang, B. Nucleic Acids Res. 45, W130–W137 (2017).
Canny, M. D. et al. Nat. Biotechnol. 36, 95–102 (2018).
Cuella-Martin, R. et al. Mol. Cell 64, 51–64 (2016).
Muerdter, F. et al. Nat. Methods 15, 141–149 (2018).
Li, W. et al. Genome Biol. 15, 554 (2014).
Wang, T. et al. Science 350, 1096–1101 (2015).
Tsai, S. Q. et al. Nat. Biotechnol. 33, 187–197 (2015).
Part of this work was carried out at the High Throughput Genome Engineering Facility and the Swedish National Genomics Infrastructure funded by Science for Life Laboratory (Scilifelab). The Knut and Alice Wallenberg Foundation, Cancerfonden, Barncancerfonden and the Academy of Finland supported this work. We thank H. Han and Y. Bryceson for providing equipment, the Protein Science Facility at Karolinska Institutet, as well as I. Sur and T. Kivioja for their comments on the manuscript.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Haapaniemi, E., Botla, S., Persson, J. et al. CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med 24, 927–930 (2018). https://doi.org/10.1038/s41591-018-0049-z
clustered regularly interspaced short palindromic repeat–Chemical and optical control of CRISPR-associated nucleases
Current Opinion in Chemical Biology (2021)
CRISPR/Cas9 cleavage triggered ESDR for circulating tumor DNA detection based on a 3D graphene/AuPtPd nanoflower biosensor
Biosensors and Bioelectronics (2021)
The development of genome editing tools as powerful techniques with versatile applications in biotechnology and medicine: CRISPR/Cas9, ZnF and TALE nucleases, RNA interference, and Cre/loxP
Gene Reports (2021)
International Journal of Molecular Sciences (2020)